Velorum Therapeutics
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Y Combinator
yc-company-directory #5496Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
sourceVelorum Therapeutics is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Velorum Therapeutics
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
10x Science
match 3010x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development. AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work. Today, that process takes months of manual, error-prone analysis that cannot keep pace with
shared product terms: therapeutic, develop, biology; shared product theme: health and clinical care; shared affiliation: Y Combinator
Serna Bio
match 25Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
shared product terms: develop, unlock, biology; shared affiliation: Y Combinator
Sensible Biotechnologies
match 25The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
shared product terms: therapeutic, medicine; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Gerostate Alpha
match 25Developing novel therapeutics for aging and chronic disease
shared product terms: therapeutic, develop; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator